# Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors

> **NCT06015802** · — · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 300 (estimated)

## Conditions studied

- Pituitary Adenoma
- Neuroendocrine Tumors

## Interventions

- **OTHER:** diagnosed and treated reasonably according to the clinical guidelines and clinical pathways

## Key facts

- **NCT ID:** NCT06015802
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-01
- **Primary completion:** 2024-03
- **Final completion:** 2029-03
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06015802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06015802, "Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06015802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
